Generic placeholder image

Current Biotechnology

Editor-in-Chief

ISSN (Print): 2211-5501
ISSN (Online): 2211-551X

Neutralizing Antibodies in HIV Treatment

Author(s): Meerza Abdul Razak, Bestha Lakshmi, Subramanyam Dasari, Pathan Shajahan Begum, Devarapogu Rajakumari and Buddolla Viswanath

Volume 5, Issue 1, 2016

Page: [11 - 27] Pages: 17

DOI: 10.2174/2211550105666151125220558

Price: $65

Abstract

Background: When a human being is infected with a virus, antibodies are produced against many epitopes or multiple virus proteins. A subset of these antibodies can block virus infection by a process that is called neutralization. Recent research has proved that Human antibodies to human immunodeficiency virus-1 (HIV-1) can neutralize a broad range of viral isolates in vitro and protect non-human primates against infection.

Methods: We review technical papers, reviews and other articles related to neutralizing monoclonal antibodies specific for HIV that are being investigated for use in HIV prevention.

Results: This review will allow to gain a more general view of the mechanism of action of neutralizing antibodies, applications of neutralizing antibodies in treating various diseases and its significant role in HIV therapeutics.

Conclusion: Most of the neutralizing antibodies are directed towards the Env, which the viruses keep mutating to avoid the host immune responses. Therefore, successful vaccines should induce antibodies that are capable of binding and neutralizing a broad spectrum of circulating viral products.

Keywords: AIDS, HIV, treatment, neutralizing antibodies, viral infections.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy